レナセラピューティクス Company Profile

Creation of new nucleic acid medicines realized through third platform technology.

Renac Therapeutics Co., Ltd. aims to create new nucleic acid drugs through a platform-based business model. Instead of a business model that derives profits by licensing out drugs developed through in-house research to pharmaceutical companies (the so-called pipeline model), we are developing a business model that collaborates with pharmaceutical companies from the drug discovery research stage and jointly develops drugs with them.